FdaApplication
ANDA 209621
Identifiers
- fda_app_no: ANDA209621
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2021-02-11 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOBRAMYCIN SULFATE | TOBRAMYCIN SULFATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION |
| TOBRAMYCIN SULFATE | TOBRAMYCIN SULFATE | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
2 products